Neutrophil Gelatinase-Associated Lipocalin (NGAL): an early marker for diabetic nephropathy

  • Mohamad Fathimah
  • Mohd Kasim Alicezah
  • Malathi Thevarajah
Original Article


Neutrophil gelatinase-associated lipoprotein (NGAL) represents a novel biomarker for early identification of acute kidney injury. This study evaluates the usefulness of urine NGAL as a marker for the early detection of diabetic nephropathy. This is a cross-sectional study which involved ninety patients with diabetes mellitus and thirty healthy controls. The diabetic patients were categorized into three groups based on their urine albumin/creatinine ratio (UACR); normoalbuminuria (<3.5 mg/mmol), microalbuminuria (3.5–35 mg/mmol), macroalbuminuria (>35 mg/mmol). In addition to urine NGAL, HbA1C, serum creatinine, urine albumin/creatinine ratio, serum cystatin C, and urine protein were assessed to determine their correlation with urine NGAL. Data analysis was done by using SPSS and MiniTab. Urine NGAL was elevated in all groups of diabetic patients with respect to controls. It was increased proportionately to the severity of kidney function. It was also elevated in some normoalbuminuria diabetic patients. Analysis of correlation revealed that urine NGAL was not correlated with glycemic indices (HbA1C and fasting blood glucose). However, urine NGAL correlated significantly with cystatin C, serum creatinine, urine albumin/creatinine ratio, and inversely with eGFR. Besides, it is also shown to have a significant correlation with eGFR in advanced kidney disease (eGFR < 30 ml/min per 1.73 min2). Urine NGAL can be used as a non-invasive tool for the early detection and assessment of the severity of diabetic nephropathy.


NGAL Diabetic nephropathy Chronic kidney disease 


  1. 1.
    American Diabetes Association. Standards of medical care in diabetes (Position Statement). Diabetes Care 2004;27 (Suppl. 1):S15–S35.Google Scholar
  2. 2.
    Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352:213–9.PubMedCrossRefGoogle Scholar
  3. 3.
    DeFronzo RA. Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev. 1995;3:510–64.Google Scholar
  4. 4.
    Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17:2974–84.PubMedCrossRefGoogle Scholar
  5. 5.
    Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol. 2007;156:203–12.PubMedCrossRefGoogle Scholar
  6. 6.
    Uttenthal O. NGAL: a marker molecule for the distressed kidney? Clin Lab Internat. 2005;29:39–41.Google Scholar
  7. 7.
    Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 1997;45:17–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–38.PubMedCrossRefGoogle Scholar
  9. 9.
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 (Suppl 1):S1–266.Google Scholar
  10. 10.
    Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71:967–70.PubMedCrossRefGoogle Scholar
  11. 11.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009;32:91–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52:595–609.PubMedCrossRefGoogle Scholar
  13. 13.
    Bonventre JV. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol. 2007;156:213– 19.Google Scholar
  14. 14.
    Ronco C. N-GAL: diagnosing AKI as soon as possible. Crit Care. 2007;11:173.PubMedCrossRefGoogle Scholar
  15. 15.
    Nielsen BS, Borregaard N, Bundgaard JR, et al. Induction of NGAL synthesis in epithelial cells of humancolorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Carlson M, Raab Y, Seveus L, et al. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut. 2002;50:501–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest. 1995;55:125–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101–08.PubMedCrossRefGoogle Scholar
  19. 19.
    Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008;23:403–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008;23:414–16.PubMedCrossRefGoogle Scholar
  21. 21.
    Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373–78.PubMedGoogle Scholar
  22. 22.
    Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res. 2008;31:255–58.PubMedCrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2012

Authors and Affiliations

  • Mohamad Fathimah
    • 1
  • Mohd Kasim Alicezah
    • 1
  • Malathi Thevarajah
    • 1
  1. 1.Department of Pathology, Faculty of MedicineUniversity MalayaKuala LumpurMalaysia

Personalised recommendations